Showing results (31-40 of 62) with videos related to
Sort By:
Pageof 7
Journal of Clinical Immunology|April 14, 2016
A Difficult and Rare Diagnosis of Autoimmune Enteropathy in a Patient Affected by Down SyndromeAnne Depince-Berger, Clara Cremilieux, Melanie Rinaudo-Gaujous, et al.International Journal of Molecular Sciences|September 9, 2022
Validation Study of a New Random-Access Chemiluminescence Immunoassay Analyzer i-TRACK10<sup>®</sup> to Monitor Infliximab and Adalimumab Serum trough Levels and Anti-Drug AntibodiesAnne Emmanuelle Berger, Aude Gleizes, Louis Waeckel, et al.Journal of Neurology|May 16, 2019
Relevance of anti-HNK1 antibodies in the management of anti-MAG neuropathiesEmilien Delmont, Shahram Attarian, Jean-Christophe Antoine, et al.Journal of Clinical Medicine|May 28, 2019
Infliximab Induced a Dissociated Response of Severe Periodontal Biomarkers in Rheumatoid Arthritis PatientsMélanie Rinaudo-Gaujous, Vincent Blasco-Baque, Pierre Miossec, et al.Inflammatory Bowel Diseases|January 15, 2014
Association between 6-thioguanine nucleotides levels and clinical remission in inflammatory disease: a meta-analysisAmelie Carla Moreau, Stephane Paul, Emilie Del Tedesco, et al.Inflammatory Bowel Diseases|May 17, 2014
Pharmacokinetics of adalimumab in inflammatory bowel diseases: a systematic review and meta-analysisStephane Paul, Amelie Carla Moreau, Emilie Del Tedesco, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2013
Association between pharmacokinetics of adalimumab and mucosal healing in patients with inflammatory bowel diseasesXavier Roblin, Hubert Marotte, Melanie Rinaudo, et al.International Journal of Colorectal Disease|April 17, 2020
Infliximab levels and antibodies in IBD-related peripheral arthralgiaAsaf Levartovsky, Bella Ungar, Miri Yavzori, et al.Inflammatory Bowel Diseases|July 2, 2024
Proactive Therapeutic Drug Monitoring Is Associated With Increased Drug Persistence in Patients With Inflammatory Bowel Disease Treated With Intravenous VedolizumabRachel Porth, Tina Deyhim, Samantha Zullow, et al.Journal of Clinical Medicine|May 27, 2023
Development of Antibodies to Ustekinumab Is Associated with Loss of Response in Patients with Inflammatory Bowel DiseaseXavier Roblin, Gérard Duru, Konstantinos Papamichael, et al.Pageof 7